Hepatitis E in a Portuguese cohort of human immunodeficiency virus positive patients: High seroprevalence but no chronic infections
Open Access
- 20 May 2022
- journal article
- research article
- Published by Wiley in Health Science Reports
- Vol. 5 (3) , e624
Abstract
Introduction: Hepatitis E virus (HEV) infection causes zoonotic hepatitis in Europe, with a higher risk of complications in immunocompromised hosts. HEV natural history in human immunodeficiency virus (HIV) positive patients is not fully understood, and its prevalence is unknown.Objectives: To study the seroprevalence of HEV and prevalence of chronic HEV in HIV‐positive patients from Porto, Portugal.Methods: We randomly selected patients from the cohort of HIV‐positive patients followed in our hospital. We performed an enzyme‐linked immunosorbent assay to search for immunoglobulin G for HEV. When the absorbance/cut‐off was inferior to 3.5, the test was repeated, and a confirmatory test executed in that sample. For reactive tests and for immunosuppressed patients (CD4 count < 200/mm3) with nonreactive test, a polymerase chain reaction (PCR) test was also performed.Results: We included 299 patients. The mean age was 48 and 75.3% were men. Regarding HIV infection, the median follow‐up time was 10 years, the acquisition was mainly heterosexual contact, and 94% were on antiretroviral therapy. Seventy‐six patients (25.4%) had reactive immunoglobulin G (IgG) hepatitis E serology. Patients with a reactive test were older (statistically significant difference). Otherwise, there was no difference between groups concerning birthplace, rural residence, chronic viral hepatitis coinfection, or cirrhosis. Nadir and actual TCD4+ lymphocyte counts did not differ significantly from patients with HEV reactive and nonreactive serology. Gamma‐glutamyl‐transferase (GGT) was higher in patients with reactive IgG HEV. All serum HEV PCR tests were negative.Conclusions: Seroprevalence of HEV was 25.4% in HIV‐positive patients. Older age and higher GGT correlated to HEV reactive IgG test. No cases of current hepatitis E were found.Keywords
This publication has 32 references indexed in Scilit:
- Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011Eurosurveillance, 2015
- Seroprevalence and Incidence of hepatitis E in Blood Donors in Upper AustriaPLOS ONE, 2015
- Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donorsThe Journal of Infection in Developing Countries, 2014
- Incidence and natural history of hepatitis E virus coinfection among HIV-infected patientsAIDS, 2014
- Transfusion-transmitted hepatitis E in Germany, 2013Eurosurveillance, 2014
- Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012Eurosurveillance, 2013
- Hepatitis E virus in Scottish blood donorsVox Sanguinis, 2013
- Hepatitis E Virus Seroprevalence among Men Who Have Sex with Men, United KingdomEmerging Infectious Diseases, 2013
- Elevated levels of thrombin‐generating microparticles in stored red blood cellsVox Sanguinis, 2013
- A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virusJournal of Virological Methods, 2006